We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$145M
AUM Growth
+$8.65M
Cap. Flow
+$1.37M
Cap. Flow %
0.94%
Top 10 Hldgs %
22.7%
Holding
101
New
2
Increased
42
Reduced
31
Closed
2

Top Buys

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$1.64M
2
BBH icon
VanEck Biotech ETF
BBH
+$519K
3
STT icon
State Street
STT
+$441K
4
MA icon
Mastercard
MA
+$274K
5
OMC icon
Omnicom Group
OMC
+$267K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.93M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$305K
3
WFC icon
Wells Fargo
WFC
+$271K
4
AMGN icon
Amgen
AMGN
+$207K
5
MMM icon
3M
MMM
+$175K

Sector Composition

Rank Sector Weight
1 Industrials 14.79%
2 Technology 13.37%
3 Consumer Staples 10.59%
4 Financials 10.11%
5 Healthcare 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBH icon
51
VanEck Biotech ETF
BBH
$397M
$1.3M 0.9%
13,628
+5,790
+74% +$519K
ABT icon
52
Abbott
ABT
$182B
$1.29M 0.89%
31,654
+1,262
+4% +$49.6K
VTI icon
53
Vanguard Total Stock Market ETF
VTI
$655B
$1.19M 0.82%
11,680
– –
JNJ icon
54
Johnson & Johnson
JNJ
$641B
$1.19M 0.82%
11,340
+700
+7% +$70.8K
AMLP icon
55
Alerian MLP ETF
AMLP
$12.7B
$1.18M 0.81%
12,420
+991
+9% +$90.3K
IAU icon
56
iShares Gold Trust
IAU
$63.4B
$1.07M 0.74%
41,575
-280
-0.7% -$7K
AOR icon
57
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.64B
$949K 0.66%
23,452
+810
+4% +$32K
PG icon
58
Procter & Gamble
PG
$346B
$942K 0.65%
11,987
+378
+3% +$30.5K
VEU icon
59
Vanguard FTSE All-World ex-US ETF
VEU
$65.9B
$893K 0.62%
17,095
-190
-1% -$9.79K
AMJ
60
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$840K 0.58%
16,055
-170
-1% -$8.37K
HD icon
61
Home Depot
HD
$335B
$806K 0.56%
9,960
-200
-2% -$15.8K
IBM icon
62
IBM
IBM
$204B
$780K 0.54%
4,502
+418
+10% +$75.2K
DUK icon
63
Duke Energy
DUK
$100B
$651K 0.45%
8,785
– –
DIS icon
64
Walt Disney
DIS
$168B
$628K 0.43%
7,330
+560
+8% +$45.7K
PFE icon
65
Pfizer
PFE
$141B
$599K 0.41%
21,301
+685
+3% +$19.5K
BXP icon
66
Boston Properties
BXP
$11B
$577K 0.4%
4,885
– –
OXY icon
67
Occidental Petroleum
OXY
$54.6B
$497K 0.34%
5,057
+673
+15% +$63.3K
MRK icon
68
Merck
MRK
$323B
$454K 0.31%
8,232
– –
JPM icon
69
JPMorgan Chase
JPM
$947B
$436K 0.3%
7,581
+165
+2% +$9.28K
KMB icon
70
Kimberly-Clark
KMB
$37B
$433K 0.3%
4,068
– –
NEE icon
71
NextEra Energy
NEE
$185B
$424K 0.29%
16,560
+2,000
+14% +$48.7K
FAST icon
72
Fastenal
FAST
$54.7B
$416K 0.29%
33,680
– –
CTAS icon
73
Cintas
CTAS
$84.4B
$411K 0.28%
25,916
– –
SYK icon
74
Stryker
SYK
$129B
$398K 0.28%
4,724
– –
NEWS
75
DELISTED
NewStar Financial, Inc.
NEWS
$397K 0.27%
28,262
-10,000
-26% -$127K
1 2
3
4 5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
CWM
Cordatus Wealth Management Newtown, Pennsylvania $420M AUM 24.63% 1-Year Est. Return
MG
MilWealth Group Milwaukee, Wisconsin $420M AUM 12.37% 1-Year Est. Return
HWMG
Hurlow Wealth Management Group Bloomington, Indiana $420M AUM 16.85% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
LSWM
Lorne Steinberg Wealth Management Montreal, Quebec, Canada $422M AUM 23.86% 1-Year Est. Return
IMA
Investment Management Associates Greenwood Village, Colorado $420M AUM 11.81% 1-Year Est. Return

Boston Research & Management's Q2 2014 Portfolio in Review

As of Q2 2014, Boston Research & Management held 101 positions worth $145M, up 6.4% from $136M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 4%. Boston Research & Management opened 2 new positions and exited 2, leaving the 101-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Boston Research & Management's largest Q2 2014 buy was The Mosaic Company: 33,360 shares worth $1.65M.
  • Boston Research & Management added most to VanEck Biotech ETF in Q2 2014, an estimated $519K increase.
  • Boston Research & Management's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $305K.
  • Boston Research & Management fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2014, selling an estimated $1.93M.
  • Boston Research & Management's ten largest holdings make up 23% of its $145M portfolio in Q2 2014.
  • Boston Research & Management opened 2 new positions and closed 2 in Q2 2014.
  • Boston Research & Management's portfolio value rose 6.4% quarter-over-quarter to $145M.

Based on Boston Research & Management's 13F filing for Q2 2014, filed 12 Aug 2014.